TRIAMCINOLONE 0.1 OINTMENT SKIN
TRIAMCINOLONE 0.1 OINTMENT FREE

TRIAMCINOLONE 0.1 OINTMENT SKIN

The area of skin to be treated may be thoroughly cleansed before topical application to reduce the risk of infection however, some clinicians believe that, unless an occlusive dressing is used, cleansing of the treated area is unnecessary and may be irritating.Īpply cream, lotion, or ointment sparingly in a thin film and rub gently into the affected area. (See Hypothalamic-Pituitary-Adrenal Axis Suppresion and also Systemic Effects, under Cautions.)įor dermatologic use only avoid contact with eyes.

TRIAMCINOLONE 0.1 OINTMENT FREE

Patients applying a topical corticosteroid to a large surface area and/or to areas under occlusion should be evaluated periodically for evidence of hypothalamic-pituitary-adrenal (HPA)-axis suppression by appropriate endocrine testing (e.g., ACTH stimulation, plasma cortisol, urinary free cortisol). Lotions, gels, and aerosols may be used on hairy areas, particularly the scalp.įormulation affects percutaneous penetration and subsequent activity extemporaneous preparation or dilution of commercially available products with another vehicle may decrease effectiveness. Lotions are probably best for treatment of weeping eruptions, especially in areas subject to chafing (e.g., axilla, foot, groin). Triamcinolone (Topical) Dosage and Administration GeneralĬonsider location of the lesion and the condition being treated when choosing a dosage form.Ĭreams are suitable for most dermatoses, but ointments may also provide some occlusion and are usually used for the treatment of dry, scaly lesions. Triamcinolone acetonide paste used as an adjunct for temporary symptomatic relief of oral inflammatory or ulcerative lesions resulting from trauma. Triamcinolone acetonide 0.1% cream and 0.1% lotion are considered to have medium-range potency. Triamcinolone acetonide 0.5% cream and 0.1% ointment are considered to have high-range potency. Response may vary from one topical corticosteroid preparation to another.Īnti-inflammatory activity may vary considerably depending on the vehicle, drug concentration, site of application, disease, and individual patient. (See Administration with Occlusive Dressing under Dosage and Administration.) Topical efficacy may be increased by using a higher concentration or occlusive dressing therapy. Topical therapy generally only controls manifestations of dermatoses eliminate cause if possible. Topical therapy generally preferred over systemic therapy fewer associated adverse systemic effects. Generally most effective in acute or chronic dermatoses (e.g., seborrheic or atopic dermatitis, localized neurodermatitis, anogenital pruritus, psoriasis, late phase of allergic contact dermatitis, inflammatory phase of xerosis). Relief of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses. Uses for Triamcinolone (Topical) Corticosteroid-responsive Dermatoses Brand names: Aristocort, Aristocort A, Flutex, Kenalog, Mytrex, Triacet

Triamcinolone 0.1 ointment